Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione | - |
Homo sapiens | |
5-bromo-6-[[(1,3-dihydroxypropan-2-yl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
5-bromo-6-[[(2,3-dihydroxypropyl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
5-bromo-6-[[(2-hydroxyethyl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
5-chloro-6-[1-(2-iminopyrrolidinyl)methyl] uracil hydrochloride | - |
Homo sapiens | |
5-chloro-6-[[(1,3-dihydroxypropan-2-yl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
5-chloro-6-[[(2-hydroxyethyl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
5-iodo-6-[[(piperidin-1-yl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
6-(((1,3-dihydroxypropan-2-yl)amino)methyl)-5-iodopyrimidine-2,4(1H,3H)-dione | the inhibitor shows a noncompetitive inhibition mode with both thymidine and inorganic phosphate substrates. Effect of 8g on cell viabilities of different cancer cell lines, overview | Homo sapiens | |
6-amino-5-bromopyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
6-[(dimethylamino)methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
6-[(dipentylamino)methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
6-[(dipropylamino)methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
6-[[(2,3-dihydroxypropyl)(methyl)amino]methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
6-[[(2-hydroxyethyl)amino]methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
6-[[bis(2-ethoxyethyl)amino]methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | - |
Homo sapiens | |
additional information | designed as transition-state analogues by mimicking the oxacarbenium ion, the pyrimidine-2,4-diones are synthesized and evaluated as inhibitors of hTP activity, kinetic mechanisms for the most potent molecule and evaluation of the interaction mode using molecular docking, overview | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
thymidine + phosphate | Homo sapiens | - |
thymine + 2-deoxy-alpha-D-ribose 1-phosphate | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P19971 | - |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
thymidine + phosphate = thymine + 2-deoxy-alpha-D-ribose 1-phosphate | SN1- and SN2-like transition states are proposed for the hTP-catalyzed reaction, overview | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
glioblastoma cell | - |
Homo sapiens | - |
U-87MG cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
thymidine + phosphate | - |
Homo sapiens | thymine + 2-deoxy-alpha-D-ribose 1-phosphate | - |
r |
Synonyms | Comment | Organism |
---|---|---|
HTP | - |
Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00002 | - |
5-chloro-6-[1-(2-iminopyrrolidinyl)methyl] uracil hydrochloride | pH and temperature not specified in the publication | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000035 | - |
pH and temperature not specified in the publication | Homo sapiens | 5-chloro-6-[1-(2-iminopyrrolidinyl)methyl] uracil hydrochloride | |
0.00012 | - |
pH and temperature not specified in the publication | Homo sapiens | 6-(((1,3-dihydroxypropan-2-yl)amino)methyl)-5-iodopyrimidine-2,4(1H,3H)-dione | |
0.001 | - |
pH and temperature not specified in the publication | Homo sapiens | 5-chloro-6-[[(1,3-dihydroxypropan-2-yl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | |
0.0056 | - |
pH and temperature not specified in the publication | Homo sapiens | 5-bromo-6-[[(1,3-dihydroxypropan-2-yl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | |
0.0084 | - |
pH and temperature not specified in the publication | Homo sapiens | 6-[(dimethylamino)methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | |
0.012 | - |
pH and temperature not specified in the publication | Homo sapiens | 6-[[(2-hydroxyethyl)amino]methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | |
0.017 | - |
pH and temperature not specified in the publication | Homo sapiens | 6-amino-5-bromopyrimidine-2,4(1H,3H)-dione | |
0.024 | - |
pH and temperature not specified in the publication | Homo sapiens | 5-bromo-6-[[(2-hydroxyethyl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | |
0.028 | - |
pH and temperature not specified in the publication | Homo sapiens | 6-[(dipentylamino)methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | |
0.034 | - |
pH and temperature not specified in the publication | Homo sapiens | 5-iodo-6-[[(piperidin-1-yl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | |
0.036 | - |
pH and temperature not specified in the publication | Homo sapiens | 6-[[(2,3-dihydroxypropyl)(methyl)amino]methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | |
0.039 | - |
pH and temperature not specified in the publication | Homo sapiens | 5-chloro-6-[[(2-hydroxyethyl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | |
0.04 | - |
pH and temperature not specified in the publication | Homo sapiens | 1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione | |
0.04 | - |
pH and temperature not specified in the publication | Homo sapiens | 5-bromo-6-[[(2,3-dihydroxypropyl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | |
0.087 | - |
pH and temperature not specified in the publication | Homo sapiens | 6-[[bis(2-ethoxyethyl)amino]methyl]-5-iodopyrimidine-2,4(1H,3H)-dione | |
0.1 | - |
above, pH and temperature not specified in the publication | Homo sapiens | 5-bromo-6-[[(2,3-dihydroxypropyl)amino]methyl]pyrimidine-2,4(1H,3H)-dione | |
0.1 | - |
above, pH and temperature not specified in the publication | Homo sapiens | 6-[(dipropylamino)methyl]-5-iodopyrimidine-2,4(1H,3H)-dione |
General Information | Comment | Organism |
---|---|---|
malfunction | overexpression of human thymidine phosphorylase (hTP) has been associated with cancer aggressiveness and poor prognosis by triggering proangiogenic and antiapoptotic signaling | Homo sapiens |